Network-based drug repositioning
Author:
Publisher
Royal Society of Chemistry (RSC)
Subject
Molecular Biology,Biotechnology
Link
http://pubs.rsc.org/en/content/articlepdf/2013/MB/C3MB25382A
Reference106 articles.
1. 2011 FDA drug approvals
2. Drug repositioning: identifying and developing new uses for existing drugs
3. Exploiting drug-disease relationships for computational drug repositioning
4. Old drugs – new uses
5. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Cited by 134 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DDCM: A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm;International Journal of Molecular Sciences;2024-05-12
2. Drug Repurposing: A Leading Strategy for New Threats and Targets;ACS Pharmacology & Translational Science;2024-04-01
3. Transcriptome-based deep learning analysis identifies drug candidates targeting protein synthesis and autophagy for the treatment of muscle wasting disorder;Experimental & Molecular Medicine;2024-04-01
4. Role of Artificial Intelligence (AI) and Machine Learning (ML) in Drug Purposing;Drug Repurposing;2024
5. Methodologies Adopted in Drug Repurposing;Drug Repurposing;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3